Evidence map›Paper›PMID 33910882›Full record

SynthesisBMJ (Clinical research ed.)2021

Delayed antibiotic prescribing for respiratory tract infections: individual patient data meta-analysis.

Beth Stuart, Hilda Hounkpatin, Taeko Becque, Guiqing Yao, Shihua Zhu, Pablo Alonso-Coello, Attila Altiner, Bruce Arroll, Dankmar Böhning, Jennifer Bostock and 14 more

Erratum issuedOpen access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in BMJ (Clinical research ed.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 76 citations in OpenAlex.

  1. [Early source control of infection in patients seen in the emergency department: a systematic review].Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2024
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Antibiotic effectiveness for children with lower respiratory infections: prospective cohort and trial in primary care.The British journal of general practice : the journal of the Royal College of General Practitioners · 2023
    Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 15 institutions in 6 countries.

Beth StuartAcademic Unit of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, UK.ORCID 0000-0001-5432-7437
Hilda HounkpatinAcademic Unit of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, UK.
Taeko BecqueAcademic Unit of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, UK.
Guiqing YaoBiostatistics Research Group, Department of Health Sciences, College of Life Sciences, University of Leicester, Leicester, UK.
Shihua ZhuAcademic Unit of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, UK.
Pablo Alonso-CoelloIberoamerican Cochrane Centre, Instituto de Investigación Biomédica Sant Pau (IIB Sant Pau-CIBERESP), Barcelona, Spain.
Attila AltinerInstitute of General Practice, Rostock University Medical Center, Rostock, Germany.
Bruce ArrollDepartment of General Practice and Primary Health Care, University of Auckland, Auckland, New Zealand.
Dankmar BöhningSouthampton Statistical Sciences Research Institute, University of Southampton, Southampton, UK.
Jennifer BostockDivision of Health and Social Care Research, King's College London, London, UK.
Heiner C BucherBasel Institute for Clinical Epidemiology and Biostatistics (CEB), University Hospital Basel and University of Basel, Switzerland.
Jennifer ChaoPediatric Emergency Medicine, State University of New York Downstate, Brooklyn, New York, USA.
Mariam de la PozaInstitut Català de la Salut, CAP Doctor Carles Ribas, Foc 112, Barcelona, Spain.
Nick FrancisAcademic Unit of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, UK.
David GillespieCentre for Trials Research, School of Medicine, College of Biomedical & Life Sciences, Cardiff University, Cardiff, UK.
Alastair D HayCentre for Academic Primary Care, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Timothy KenealyDepartment of General Practice and Primary Health Care, University of Auckland, Auckland, New Zealand.
Christin LöfflerInstitute of General Practice, Rostock University Medical Center, Rostock, Germany.
David P McCormickDepartment of Pediatrics, University of Texas Medical Branch at Galveston, Galveston, TX, USA.
Gemma Mas-DalmauInstituto de Investigación Biomédica Sant Pau (IIB Sant Pau), Barcelona, Spain.
Laura MuñozAgència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), Barcelona, Spain.
Kirsty SamuelASPIRE PPI Panel, Leeds Institute for Health Sciences, University of Leeds, Leeds, UK.
Michael MooreAcademic Unit of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, UK.
Paul LittleAcademic Unit of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, UK.
University of Southampton · GBUniversity of Auckland · NZUniversity of Rostock · DEAgència de Qualitat i Avaluació Sanitàries de Catalunya · ESCardiff University · GBCentro de Investigación Biomédica en Red · ESHospital de Sant Pau · ESInstitut Català de la Salut · ESKing's College London · GBState University of New York · USThe University of Texas Medical Branch at Galveston · USUniversity of Basel · CHUniversity of Bristol · GBUniversity of Leeds · GBUniversity of Leicester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the overall effect of delayed antibiotic prescribing on average symptom severity for patients with respiratory tract infections in the community, and to identify any factors modifying this effect.

designSystematic review and individual patient data meta-analysis. DATA SOURCES: Cochrane Central Register of Controlled Trials, Ovid Medline, Ovid Embase, EBSCO CINAHL Plus, and Web of Science. ELIGIBILITY CRITERIA FOR STUDY SELECTION: Randomised controlled trials and observational cohort studies in a community setting that allowed comparison between delayed versus no antibiotic prescribing, and delayed versus immediate antibiotic prescribing.

main outcome measuresThe primary outcome was the average symptom severity two to four days after the initial consultation measured on a seven item scale (ranging from normal to as bad as could be). Secondary outcomes were duration of illness after the initial consultation, complications resulting in admission to hospital or death, reconsultation with the same or worsening illness, and patient satisfaction rated on a Likert scale.

resultsData were obtained from nine randomised controlled trials and four observational studies, totalling 55 682 patients. No difference was found in follow-up symptom severity (seven point scale) for delayed versus immediate antibiotics (adjusted mean difference -0.003, 95% confidence interval -0.12 to 0.11) or delayed versus no antibiotics (0.02, -0.11 to 0.15). Symptom duration was slightly longer in those given delayed versus immediate antibiotics (11.4

conclusionsDelayed antibiotic prescribing is a safe and effective strategy for most patients, including those in higher risk subgroups. Delayed prescribing was associated with similar symptom duration as no antibiotic prescribing and is unlikely to lead to poorer symptom control than immediate antibiotic prescribing. Delayed prescribing could reduce reconsultation rates and is unlikely to be associated with an increase in symptoms or illness duration, except in young children. STUDY REGISTRATION: PROSPERO CRD42018079400.

Indexed as

Practice Patterns, Physicians'Anti-Bacterial AgentsDrug Administration ScheduleHumansRespiratory Tract InfectionsTime-to-TreatmentAnti-Bacterial Agents

Identifiers

PMID33910882
PMCPMC8080136
OpenAlexW3157896900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.